Continuous Metabolite Monitor Patch Global Market Report 2025

The continuous metabolite monitor patch market size has grown rapidly in recent years. It will grow from $1.71 billion in 2024 to $1.97 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth during the historic period can be attributed to the rising adoption of minimally invasive monitoring, increasing preference for real-time data tracking, improved patient compliance due to ease of use, expanding availability of connected health platforms, and growing interest from the aging population.

The continuous metabolite monitor patch market size is expected to see rapid growth in the next few years. It will grow to $3.45 billion in 2029 at a compound annual growth rate (CAGR) of 15%. The growth in the forecast period can be attributed to the increasing demand for real-time metabolic monitoring, growing need for personalized health tracking, rising consumer preference for noninvasive monitoring solutions, expanding availability of multi-metabolite monitoring patches, and increasing research and development activities in metabolite sensor technology. Key trends during the forecast period include advancements in biosensor technology, progress in noninvasive monitoring methods, innovations in multi-metabolite detection, integration of artificial intelligence and data analytics, and advancements in wearable health platforms.

The growing prevalence of chronic diseases is expected to drive the expansion of the continuous metabolite monitor patch market in the coming years. The prevalence of chronic diseases refers to the proportion of a population affected by one or more long-term health conditions such as diabetes, heart disease, or hypertension, indicating how widespread these conditions are within a community. The rise in chronic diseases is largely influenced by an aging population, as older adults are more susceptible to long-term illnesses, and with increased life expectancy, more individuals are living with chronic conditions including diabetes, heart disease, and arthritis. Continuous metabolite monitor patches help address this challenge by enabling real-time monitoring of key metabolic biomarkers, supporting early detection, better management, and personalized care for conditions such as diabetes, cardiovascular diseases, and metabolic disorders. For example, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, 76.4 percent of US adults, representing 194 million people, reported having at least one chronic condition in 2023, with prevalence rates of 59.5 percent among young adults, 78.4 percent among middle-aged adults, and 93 percent among older adults. Hence, the increasing prevalence of chronic diseases is contributing to the growth of the continuous metabolite monitor patch market.

Major companies in the continuous metabolite monitor patch market are focusing on developing innovative over-the-counter continuous glucose monitors to improve glucose tracking, enhance patient comfort, and support effective management of chronic conditions such as diabetes. Noninvasive glucose monitoring involves measuring blood glucose levels without puncturing the skin or drawing blood, using technologies such as skin sensors, optical devices, or wearable patches. For instance, in June 2024, Abbott Laboratories, a US-based healthcare company, partnered with Dexcom Inc., a US-based medical device manufacturer, to launch the first over-the-counter continuous glucose monitors (CGMs). These CGMs provide real-time readings through a smartphone application, allowing users to monitor their metabolic health without routine finger pricks. The devices offer improved accuracy, longer wear duration, and seamless connectivity, making them suitable for both diabetic and non-diabetic users seeking personalized health insights.

In May 2023, Medtronic plc, a US-based medical technology company, acquired EOFlow Co. Ltd. for an undisclosed amount. This acquisition was aimed at strengthening Medtronic’s diabetes care portfolio, enhancing its wearable insulin delivery systems, and utilizing EOFlow’s expertise in advanced insulin pump technologies to improve patient outcomes and real-time glucose management. EOFlow Co. Ltd. is a South Korea-based medical device company that specializes in the development and commercialization of continuous metabolite monitor patches.

Major players in the market are Abbott Laboratories, Dexcom Inc., Medtronic Public Limited Company, Nutromics Pty. Ltd., Ascensia Diabetes Care Holdings AG, Roche Diabetes Care Inc., LifeScan IP Holdings LLC, Profusa Inc., Biolinq Inc., Texas Instruments Incorporated, Bigfoot Biomedical Inc., Afon Technology Ltd., GraphWear Technologies Inc., i-Sens Inc., DiaMonTech AG, Medtrum Technologies Inc., PercuSense Inc., GENTAG Inc., Changzhou RECOO Healthcare Co. Ltd., and Ultrahuman Healthcare Private Limited.

North America was the largest region in the continuous metabolite monitor patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in continuous metabolite monitor patch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The continuous metabolite monitor patch market research report is one of a series of new reports that provides continuous metabolite monitor patch market statistics, including the continuous metabolite monitor patch industry's global market size, regional shares, competitors with the continuous metabolite monitor patch market share, detailed continuous metabolite monitor patch market segments, market trends and opportunities, and any further data you may need to thrive in the continuous metabolite monitor patch market. This continuous metabolite monitor patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A continuous metabolite monitor patch is a wearable device that noninvasively measures key metabolic biomarkers in real time. The patch offers valuable insights into metabolic health for both users and healthcare professionals, enabling early detection of imbalances or signs of disease. It is particularly useful for managing chronic conditions such as diabetes or enhancing athletic performance, providing a personalized and preventive method of health monitoring.

The main product types of continuous metabolite monitor patch include glucose monitoring patch, lactate monitoring patch, ketone monitoring patch, multi-metabolite monitoring patch, and others. A glucose monitoring patch is a wearable sensor that continuously measures glucose levels in interstitial fluid to help regulate blood sugar. These products are distributed through various channels such as online pharmacies, retail pharmacies, and others. They are used by different end users including hospitals, clinics, home care settings, sports and fitness centers, research institutes, and others.

The countries covered in the continuous metabolite monitor patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The continuous metabolite monitor patch market consists of revenues earned by entities providing services such as clinical trial support services, lactate and uric acid monitoring services, real-time data transmission services, critical care monitoring services, and wellness and fitness optimization services. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous metabolite monitor patch market also includes sales of sempulse halo, biolinq wearable patch, wearable sweat-sensing patches, supersapiens abbott libre sense, and nutritrek by caltech. Values in this market are ‘factory gate’ values, meaning the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.